ArticleJournal for immunotherapy of cancer2023

Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8

Anze Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.